Bupivacaine Hydrochloride from China
Bupivacaine hydrochloride is an amide-type local anesthetic with an acyclic carboxamide group, supplied as its hydrochloride salt. Under HTS 2924.19.80.00, the salt classifies with the parent acyclic amide per chapter note 3(C)(1), covering 'other' derivatives.
Duty Rate — China → United States
137.5%
Rate breakdown
9903.04.6093.5%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.3112.5%Except for products described in headings 9903.05.85–9903.05.92, articles the product of China, as provided for in U.S. note 52 to this subchapter
9903.88.0325%Except as provided in headings 9903.88.13, 9903.88.18, 9903.88.33, 9903.88.34, 9903.88.35, 9903.88.36, 9903.88.37, 9903.88.38, 9903.88.40, 9903.88.41, 9903.88.43, 9903.88.45, 9903.88.46, 9903.88.48, 9903.88.56, 9903.88.64, 9903.88.66, 9903.88.67, 9903.88.68, or 9903.88.69, articles the product of China, as provided for in U.S. note 20(e) to this subchapter and as provided for in the subheadings enumerated in U.S. note 20(f)
Import Tips
• Submit salt composition analysis showing equivalence to parent amide for tariff purposes
• Comply with 21 CFR import alerts for anesthetics and maintain cold chain documentation
• Prevent reclassification by specifying pharmaceutical end-use, avoiding bulk chemical headings